Bifogade filer
Mentice announces resignation of Chief Financial Officer
Kurs
-1,01%
Likviditet
0,15 MSEK
Prenumeration
Kalender
| Est. tid* | ||
| 2025-11-06 | 08:30 | Kvartalsrapport 2025-Q3 |
| 2025-07-24 | 08:30 | Kvartalsrapport 2025-Q2 |
| 2025-05-23 | N/A | X-dag ordinarie utdelning MNTC 0.00 SEK |
| 2025-05-22 | N/A | Årsstämma |
| 2025-05-08 | - | Kvartalsrapport 2025-Q1 |
| 2025-02-13 | - | Bokslutskommuniké 2024 |
| 2024-11-07 | - | Kvartalsrapport 2024-Q3 |
| 2024-07-23 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-24 | - | X-dag ordinarie utdelning MNTC 0.00 SEK |
| 2024-05-23 | - | Årsstämma |
| 2024-05-03 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-15 | - | Bokslutskommuniké 2023 |
| 2023-10-26 | - | Kvartalsrapport 2023-Q3 |
| 2023-07-20 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-12 | - | X-dag ordinarie utdelning MNTC 0.00 SEK |
| 2023-05-11 | - | Årsstämma |
| 2023-04-27 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-03 | - | Bokslutskommuniké 2022 |
| 2022-10-26 | - | Kvartalsrapport 2022-Q3 |
| 2022-07-21 | - | Kvartalsrapport 2022-Q2 |
| 2022-04-28 | - | X-dag ordinarie utdelning MNTC 0.00 SEK |
| 2022-04-28 | - | Kvartalsrapport 2022-Q1 |
| 2022-04-27 | - | Årsstämma |
| 2022-02-03 | - | Bokslutskommuniké 2021 |
| 2021-10-28 | - | Kvartalsrapport 2021-Q3 |
| 2021-07-22 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-07 | - | X-dag ordinarie utdelning MNTC 0.00 SEK |
| 2021-05-06 | - | Årsstämma |
| 2021-04-28 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-04 | - | Bokslutskommuniké 2020 |
| 2020-11-12 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-13 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-28 | - | X-dag ordinarie utdelning MNTC 0.00 SEK |
| 2020-05-27 | - | Årsstämma |
| 2020-05-14 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-27 | - | Bokslutskommuniké 2019 |
| 2019-11-25 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-29 | - | Kvartalsrapport 2019-Q2 |
| 2019-08-28 | - | Extra Bolagsstämma 2019 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Mentice's CFO, Gunilla Andersson, has decided to leave Mentice. Gunilla will formally leave the Company at the end of August and be replaced by an interim CFO until a new CFO has been appointed.
We are grateful for Gunilla's work over the last two years related to improved structures for financial reporting and operational efficiency. We wish Gunilla all the best in her future endeavors.
For more information, please contact:
Göran Malmberg, CEO, Mentice
E-post: goran.malmberg@mentice.com
US Mobile. +1 (312) 860 5610
Sweden Mobile +46 (0) 703 09 22 22
About Mentice
Mentice (STO: MNTC) is the world leader in proficiency based simulation solutions for image guided interventional therapies. Our solutions help healthcare professionals acquire, retain, and enhance their procedural skills driving improved productivity and outcomes. Mentice solutions are scientifically validated and have been specifically developed for healthcare providers and the medical device industry. Neurovascular, cardiovascular, and peripheral interventions are just some of the clinical areas covered by our solutions. Learn more about the features and benefits of Mentice solutions at: www.mentice.com
Marketplace| Nasdaq First North Growth Market, Stockholm | Ticker symbol MNTC
Certified Adviser| FNCA Sweden AB
This information is information that Mentice is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2023-05-29 15:05 CEST.